论文部分内容阅读
ADHD药物关键词:心血管以及精神病学问题美国FDA于2月21日责令注意缺陷多动障碍(Attention Deficit Hy-peractivity Disorder,ADHD)类药物生产厂家制定患者用药指导来提醒患者注意此类药物可能存在的心血管风险以及不良精神症状风险。
ADHD DRUGS Cardiovascular and Psychiatric Issues The FDA ordered the Attention Deficit Hy-peractivity Disorder (ADHD) manufacturers to develop guidelines on patient medication on February 21 to alert patients to the possibility of such medications The cardiovascular risk as well as the risk of adverse psychiatric symptoms.